Molecular Transport Medium Industry Projected to Grow at a 4.5% CAGR from 2024 to 2034, Reaching a Market Valuation of US$ 1,214 Million by 2034| Fact.MR Study

The value of the global molecular transport medium market was US$ 234.6 million in 2019. The market is approximated to be about US$ 785.2 million in 2024. The molecular transport medium market is anticipated to grow at a CAGR of 4.5% during the period from 2024 to 2034. The market valuation is expected to be US$ 1,214 million by 2034.

The demand for molecular sample transport medium is rising significantly with the increasing use of molecular diagnostics, including polymerase chain reaction (PCR) and nucleic acid testing. The growing need for reliable sample preservation in diagnostic tests is driving the demand for molecular transport mediums. The growth of biobanking operations are also likely to drive growth in the market.

During pandemic years of 2020 and 2021, collection and transport media were in massive demand with increased COVID-19 testing requirements. Post-2019, molecular transport medium continues to be on demand among players with increased funding into research and development in the field of biotechnology.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9527

Key Takeaways from Market Study:

The estimated market value of the global molecular transport medium market in 2024 is expected to be US$ 785.2 million, reflecting the growing demand for effective transportation of biological samples.
By 2034, the market is forecasted to reach US$ 1,214 million, marking a significant increase over the decade and showcasing the continuous advancements in molecular transport technology.
The global market for molecular transport medium is projected to grow at a steady compound annual growth rate (CAGR) of 4.5% from 2024 to 2034, driven by increasing healthcare needs and technological innovations.
The active transport medium segment is anticipated to experience a growth rate of 5.3% CAGR from 2024 to 2034, owing to the rising use of these advanced transport solutions in research and diagnostics.
The mycobacterial and fungal infection segment is expected to grow at a CAGR of 5.2% during the forecast period, spurred by the increasing focus on diagnosing and monitoring infectious diseases.
The nasal washes and swab segment is predicted to grow at a CAGR of 5.1% from 2024 to 2034, driven by the rising demand for sample collection methods used in diagnostic testing.
North America is projected to hold a market share of 4.8% in 2024, reflecting the region's established healthcare infrastructure and high demand for molecular transport mediums in diagnostics and research.
East Asia is expected to account for 5.3% of the market share in 2024, with increasing investment in healthcare facilities and research capabilities fueling growth in molecular transport medium usage.

Leading Players Driving Innovation in the Molecular Transport Medium Market:

Thermo Fisher Scientific Inc.; Becton, Dickinson, and Company; Cardinal Health; Quidel Corporation; Medical Wire & Equipment; COPAN Diagnostics Inc.; Titan Biotech Ltd.; Alpha Teknova, Inc. [former named Teknova]; Bio-Genex Laboratories Inc.; EKF Diagnostics; Trinity Biotech; Alpha-Tec Systems, Inc.; Charm Sciences, Inc.; Azer Scientific; bioBoaVista; AccuGene; KSL Diagnostics; Puritan Medical Products; Amazing Biotech (Shanghai) Co., Ltd.

Country-wise Insights:

The combined demand for molecular transport mediums in the United States, Canada, and Mexico is estimated to be worth US$ 323 million in the year 2024. Thanks to liberal market conditions, collection of molecules, and the availability of a number of transport medium market players, North American nations operate in alliance with biotech and pharmaceutical companies.

These nations ensure the integrity of the biological samples utilized in drug discovery, fueling the growth of the market.

With a very advanced network of microbiological research centers, the United States is the largest user of molecular transport mediums in North America. The net income realised from biological sample preservation and transportation medium sales within the nation was estimated to stand at approximately US$ 295 million in the year 2024.

Good RNA extraction and transport mediums find higher demand within the United States because they play a crucial role in molecular testing by the expansive network of research institutes that is biopharmaceutical in nature.

The US market is anticipated to grow at a CAGR of 4.9% during the forecast period until 2034. The Canadian and Mexican markets are anticipated to grow at CAGRs of 3.4% and 2.4%, respectively, during the forecast period.

Browse Full Report: https://www.factmr.com/report/molecular-transport-medium-market

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global irritable bowel syndrome treatment market, presenting historical data for 2019 to 2023 and forecast statistics for 2024 to 2034.

The molecular transport medium market is segmented by product type, application, sample, end-user verticals, and region. In terms of product type, the market is divided into active transport mediums and inactivated transport mediums, each serving different needs in biological sample transportation.

Applications for molecular transport mediums include viruses such as COVID-19, Middle East Respiratory Syndrome (MERS), influenza, HIV, rhinovirus, adenovirus, and respiratory syncytial virus (RSV), along with bacterial infections like Staphylococcus pneumonia, Haemophilus influenza, anthrax, atypical bacteria, mycoplasma, Q-fever, mycobacterial and fungal infections. The samples transported using these mediums include nasal washes and swabs, sputum, saliva, fecal and stool samples, urine, blood, tissues, and other sample types.

Check out More Related Studies Published by Fact.MR:

Swab and Viral Transport Medium Market - https://www.factmr.com/report/5221/swab-and-viral-transport-medium-market

Molecular Diagnostics Reagent Market - https://www.factmr.com/report/molecular-diagnostics-reagent-market

Swab Sticks Market - https://www.factmr.com/report/swab-sticks-market

Adult Hemoglobinopathy Testing Market - https://www.factmr.com/report/adult-hemoglobinopathy-testing-market

PCR and Real-time PCR Molecular Diagnostics Market - https://www.factmr.com/report/5247/pcr-and-realtime-pcr-molecular-diagnostics-market

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.